Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia

Multi-center Survey on Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04484311

Acronym

NC-ESD

Enrollment

300

Registered

2020-07-23

Start date

2020-08-01

Completion date

2020-12-31

Last updated

2020-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms, Esophageal Neoplasms, Gastric Neoplasm

Keywords

Endoscopic therapy, Endoscopic submucosal dissection

Brief summary

Short and long outcomes of ESD are well described, particularly in Eastern series. However, the outcome of non-curative ESDs is scarcely reported in the west (particularly among non-gastric or submucosal lesions). Therefore, the aim of this project is to describe the European experience with non-curative ESDs, analysing all the consecutive ESDs performed in several reference centers, assessing the presence of residual lesion in the endoscopic follow-up or in the surgical specimen.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients submitted to ESD due to neoplastic lesions of the gastrointestinal tract

Exclusion criteria

* Patients without endoscopic follow-up or surgery will be excluded from the analysis

Design outcomes

Primary

Measure	Time frame	Description
Residual neoplasia	2010-2020	Presence of residual neoplasia after non-curative ESD

Countries

Portugal

Contacts

Primary ContactJoão Santos-Antunes, MD, MSc

joao.claudio.antunes@gmail.com+351917490406

Backup ContactGuilherme Macedo, MD, PhD

guilhermemacedo59@gmail.com

Outcome results